Rigel Pharmaceuticals reported $186.52M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Acura Pharmaceuticals ACUR:US 1.9M 22K
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Amgen AMGN:US $ 64993M 5220M
Anika Therapeutics ANIK:US $ 352.93M 10.2M
Applied Genetic Technologies AGTC:US $ 110.41M 16.56M
Astrazeneca AZN:US $ 107221M 33580M
AstraZeneca AZN:LN 107221M 33580M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bristol Myers Squibb BMY:US $ 110893M 96M
Celldex Therapeutics CLDX:US $ 460.2M 255.65M
Chemocentryx CCXI:US $ 454.84M 12.83M
Daiichi Sankyo 4568:JP Y 2110729M 48259M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Eli Lilly And LLY:US $ 48187M 378M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Halozyme Therapeutics HALO:US $ 1185.42M 159.56M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Immunogen IMGN:US $ 296.8M 4.64M
Intrexon XON:US $ 376.9M 25.67M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Ligand Pharmaceuticals LGND:US $ 1273.66M 17.37M
Macrogenics MGNX:US $ 392.16M 33.75M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Rigel Pharmaceuticals RIGL:US $ 186.52M 15.08M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
Veracyte VCYT:US $ 1186.36M 158.92M